Do Remissions in Acute Leukemia
- 1 March 1972
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 129 (3) , 498-499
- https://doi.org/10.1001/archinte.1972.00320030118017
Abstract
The concept that acute leukemia is a disease of rapid uncontrolled proliferation of marrow cells was first questioned by Astaldi and Mauri in 1954.1 These investigators cultured marrow from patients with acute leukemia in the presence of colchicine and demonstrated a very low mitotic index. From this simple study the authors concluded that the increased number of primitive cells in the marrow of leukemic patients is the result, not of rapid proliferation, but rather of an accumulation of slowly dividing cells that fail to differentiate. Twelve years later a more sophisticated approach was applied to the study of cellular proliferation in which tritiated thymidine, a radioactive nucleic acid precursor, was administered to patients with acute leukemia.2 These experiments confirmed the observations of Astaldi and Mauri. All primitive cells within the bone marrow have the same genetic code, but expression of genetic DNA is variable. This variability is accomplishedThis publication has 5 references indexed in Scilit:
- Fall in Liver DNA Polymerase Activity in Cortisone-treated RatsNature, 1970
- The Effect of Vincristine on the Platelet Count in RatsBritish Journal of Haematology, 1970
- Pseudoleukemia During Recovery from Dapsone-Induced AgranulocytosisAnnals of Internal Medicine, 1968
- Increased template activity of liver chromatin, a result of hydrocortisone administration.Proceedings of the National Academy of Sciences, 1965
- Action of Hydrocortisone on Cells in Tissue Culture.Experimental Biology and Medicine, 1954